Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Stocks Open Higher on Vaccine Optimism, M&A Fever; Dow up 335 Points

Published 09/14/2020, 09:28 AM
Updated 09/14/2020, 09:36 AM
© Reuters.

© Reuters.

By Geoffrey Smith 

Investing.com -- U.S. stock markets opened sharply higher on Monday, as encouraging newsflow over the weekend on the hunt for a vaccine to treat the Covid-19 virus helped to restore confidence in the ability of the market to bounce from last week's setback. 

By 10:10 AM ET (1410 GMT), the Dow Jones Industrial Average was up 335 points, or 1.2% at 28,001 points, while the S&P 500 was up 1.6% and the Nasdaq Composite was up 2.2%. The corrections in both of the latter indexes had stopped on Friday more or less in line with their respective 50-day moving averages, a development that leaves them well placed to rebound this week, according to some technical analysts.

Last week had been the worst since March for the major boards, but the weekend brought some relief, as Pfizer (NYSE:PFE) CEO Albert Bourla told CBS that the company's vaccine could be ready for distribution within the U.S. by the end of the year. Pfizer stock was up 1.3%, while the stock of its partner in Covid vaccine development, German-based Biontech (NASDAQ:BNTX), was up 4.8%.  

The market was also supported by the news of some big acquisitions over the weekend, with chipmaker Nvidia (NASDAQ:NVDA)'s stock rising 8.1% on the back of its $40 billion cash-and-stock acquisition of U.K. chip designer ARM from Softbank (OTC:SFTBY), and Immunomedics (NASDAQ:IMMU) stock more than doubling after Gilead Sciences (NASDAQ:GILD) offered to pay $21 billion for the biotech company. 

The Nvidia acquisition would transform it into a global leader in chipset design. For that reason, the Chinese-based Global Times argued on Monday that Beijing could be inclined to refuse antitrust clearance, fearing that Huawei would no longer have access to ARM's designs. 

More positively for broader market sentiment, the dispute over Chinese video-streaming service TikTok appears to be nearing a resolution, after Oracle (NYSE:ORCL) confirmed it had been chosen by TikTok's owner ByteDance to be the service's 'trusted technology partner' in the U.S., edging out Microsoft (NASDAQ:MSFT) and Walmart (NYSE:WMT).  Oracle stock rose 4.8%, while Microsoft stock rose 1.7%. 

Among the losers were - once again - oil and gas stocks, as crude prices extended last week's decline in response to a gloomier forecast from the Organization of Petroleum Exporting Countries. OPEC's monthly oil market report revised down its forecast for global oil demand to by an average of 400,000 barrels a day to 90.2 million b/d, and also warned that it expects the weakness in Asian demand to last through the first half of 2021. Even more alarmingly. U.K. oil major updated its long-term forecasts to reflect its assumption that global oil demand will peak much earlier than previously reckoned. BP (NYSE:BP)'s latest energy outlook assumes global demand will plateau by the middle of the current decade before going into long-term decline as alternative energy sources displace it.

Exxon Mobil (NYSE:XOM) stock fell 0.4% while Occidental Petroleum (NYSE:OXY) stock fell 2.2%.

 

 

Latest comments

hi im dev
stocks open higher on vaccine setbacks, vaccine hopes, vaccine doubts, vaccine cancellations, vaccine failures....just change all future headlines to "stocks open higher on day ending in "Y""
Boring...
Fake news. Recent surveys show most in the US (65%) would not get vaccine. Trumpers are anti-vacs and Biden people don’t trust it to be safe.
Can you share link please. I would say that 65 percent is quite low.
Who is net buyers at this time . Why keep buying high on all stocks
They dont know why it goes up so they just stick vaccines news into all up or down moves.
SoftBank is selling tech. Shouldn't you?
You always pull out the same funny headline about the vaccine please change to a new funny joke
There wont be a second crash till vaccine is out. Dont listen to these whiner who missed the chance to buy in.
Hope Bubble
a story was floated out yesterday late afternoon on Pfizer vaccine by the end of this year. Complete garbage and cover for the Federal Reserve to buy up the market and prop the stock values in an effort to stop the decline over the last couple of weeks. I'm thinking that investors will continue to sell, the stupidity of all this is running thin. Next will be Kudlow going on TV and saying we have an amazing recovery going on or China phase 1 going great. Can't make this stuff up.
WWJD: What Would Jerome Do?
Vaccine how long hopes
I dont know stocks open higher on vaccine hope or you want to make it
Xx 😙🛷
I dont know whether stocks open  higher on vaccine optimism or you want to make it
Always "vaccine hope"...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.